Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|July 18, 2006
Cytokine expression patterns associated with systemic adverse events following smallpox immunizationBrett A McKinney, David M Reif, Michael T Rock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2012
A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnelWilliam P Goins, Kathryn M Edwards, Cindy L Vnencak-Jones, et al.
Journal of Virology|April 14, 2005
Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responsesXuemin Chen, Michael T Rock, Jason Hammonds, et al.
The Journal of Infectious Diseases|May 6, 2008
Genetic basis for adverse events after smallpox vaccinationDavid M Reif, Brett A McKinney, Alison A Motsinger, et al.
Science Translational Medicine|April 8, 2010
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virusSurender Khurana, Wanida Chearwae, Flora Castellino, et al.
Experimental Hematology|August 14, 2012
Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survivalBrian G Engelhardt, Salyka M Sengsayadeth, Madan Jagasia, et al.
JAMA|September 9, 2004
Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trialThomas R Talbot, Jack T Stapleton, Rebecca C Brady, et al.
Plos One|June 7, 2014
Small intestinal intraepithelial TCRγδ+ T lymphocytes are present in the premature intestine but selectively reduced in surgical necrotizing enterocolitisJörn-Hendrik Weitkamp, Michael J Rosen, Zhiguo Zhao, et al.
Gut|January 24, 2012
Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratiosJörn-Hendrik Weitkamp, Tatsuki Koyama, Michael T Rock, et al.
The American Journal of Tropical Medicine and Hygiene|October 29, 2009
Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteersPeter F Wright, Anna P Durbin, Stephen S Whitehead, et al.
Pageof 3